7,892 trials (keyword fallback)
Low Back Pain
Primary: Difference in Percent Change From Baseline in L4 Paraspinal Cross-Sectional Area Asymmetry at 6 Weeks Between Intervention Arms — 0; -17.6 % change — p=1.000
Statin-related Muscle Pain · Muscle Aches · Muscle Weakness
Primary: Change in Pre- and Post-phosphocreatine Relaxation Time — 5.58; 5.083 milliseconds
Saphenous Vein Graft Disease
Primary: Saphenous Vein Graft Occlusion (Percentage of Vein Grafts Occluded) Based on CT Coronary Angiography at 1 Year — 14; 16 Vein grafts
Dyslipidemias
Primary: Peak Oxygen Consumption — 43.8; 51.6; 53.5 percentage of predicted value
Amputation
Primary: Residual Limb Hip Muscle Peak Torque at Baseline — 25.6; 14.9; 25.6; 13.1 newton-meters / kg*meters
Hyperlipidemia · Insulin Resistance · Type 2 Diabetes
Primary: Steady-state Plasma Glucose (SSPG) — 130; 139 mg/dL — p=0.01
Muscular Atrophy
Primary: The Percent Change in Bilateral Thigh Lean Mass Density (Grams) as Measured by DEXA Scan Will be Compared Between Baseline and After 5-days of Bed Rest — -3.845; -0.249…
Muscle Relaxants
Primary: Fade on Train of Four Stimulation — 0.85; 0.64; 0.66; 0.68 Ratio
Myopathic Symptoms
Primary: Number of Participants With Reduction in Myopathic Pain — 4; 4 Participants
Sarcopenia
Primary: Muscle Satellite Cells — 3.2; 3.2; 4.0; 3.8 Number of Pax7+ cells/muscle fiber
Chronic Pain
Primary: Medical Record Review and Treatment Utilization Form — 19; 17 Participants — p=.6469
Colorectal Cancer
Primary: Feasibility, Assessed by Examining Number of Participants Accrued — 20 Participants
Spinal Cord Injuries
Primary: HF Muscle Force — 23.9; 30.9 Newtons (N)
Chronic Pain
Primary: System Usability Scale (SUS) — 79.6 score on a scale
Pain, Postoperative
Primary: Postoperative Pain on a Visual Analogue Pain Scale at One Hour Postoperatively — 4.04; 5.09; 4.4 units on a scale